As a communicator between lung parenchymal cells and inflammatory cells, as well as a connector between intracellular components and ECM, CCN1 might be a potential cellular therapeutic target for ALI/ARDS. This evidence concerns the gene CCN1 and acute respiratory distress syndrome.